These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28257461)

  • 1. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
    PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
    Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging with [
    Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z
    Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Weng CC; Huang SL; Chen ZA; Lin KJ; Hsiao IT; Yen TC; Kung MP; Wey SP; Hsu CH
    Ann Nucl Med; 2017 Aug; 31(7):506-513. PubMed ID: 28451991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
    Chao KT; Tsao HH; Weng YH; Hsiao IT; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lin KJ
    Synapse; 2012 Sep; 66(9):823-31. PubMed ID: 22623146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).
    Toomey JS; Bhatia S; Moon LT; Orchard EA; Tainter KH; Lokitz SJ; Terry T; Mathis JM; Penman AD
    PLoS One; 2012; 7(6):e39041. PubMed ID: 22723923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT
    PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
    Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
    Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
    Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements.
    Lin KJ; Lin WY; Hsieh CJ; Weng YH; Wey SP; Lu CS; Skovronsky D; Yen TC; Chang CJ; Kung MP; Hsiao IT
    Nucl Med Biol; 2011 Nov; 38(8):1149-55. PubMed ID: 21831650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.